Japan is leading the way in developing and taking Regenerative Medicine to market. Here is a pretty list of the players in this space.
I feel the the US will need to step up their game and compete with a fast tracked Japan.
MSB stands to attract increased interest from both the US and Japan with regard to their tier 1 and late stage products.
I place a speculative buy on MSB at these levels and will be buying! DYOR
Japanese Market participants
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.05 |
Change
0.078(7.99%) |
Mkt cap ! $1.196B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.06 | 99.0¢ | $3.864M | 3.759M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 91326 | $1.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.05 | 117327 | 18 |
View Market Depth
| Last trade - 14.43pm 04/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |